Tag: Charles Baum

Bristol Myers Squibb to acquire Mirati Therapeutics in $4.8bn deal

businessnewstoday- October 9, 2023

Bristol Myers Squibb (NYSE: BMY) is set to acquire Mirati Therapeutics, Inc. (NASDAQ: MRTX) at $58.00 per share in a cash deal valued at $4.8 ... Read More